Hematological Malignancies: Current Perspectives on Diagnosis, Prognosis, and Treatment.

October 7, 2008

This supplement to ONCOLOGY provides a comprehensive look at state-of-the-art management of three of the most prevalent hematological malignancies in the US today.

This supplement to ONCOLOGY provides a comprehensive look at state-of-the-art management of three of the most prevalent hematological malignancies in the US today: chronic lymphocytic leukemia, non-Hodgkin lymphoma, and acute myeloid leukemia. This supplement is supported by an educational grant from Cephalon Oncology, and is jointly sponsored by Postgraduate Institute for Medicine and Vital Issues in Medicine. CME/PE/CE credit is available. 
Continue To Supplement...